Treatment-induced effects can mimic tumor recurrence and pose a challenge to accurately assessing treatment response. We aim to provide a machine learning framework and identify important imaging features for discriminating treatment-induced injury from recurrent glioblastoma at biopsy level resolution. Our best model performs with a mean AUC of .77+/-0.11 across 4 fold cross-validation of 108 tissue samples. rCBV, choline-to-NAA index (CNI), and normalized lipid levels were the top three most import features in distinguishing treatment effects from recurrent tumor.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords